SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-049058
Filing Date
2019-02-25
Accepted
2019-02-25 08:16:02
Documents
4
Period of Report
2019-02-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d712065d8k.htm 8-K 15938
2 EX-99.1 d712065dex991.htm EX-99.1 25580
3 GRAPHIC g712065g0225065525378.jpg GRAPHIC 1379
4 GRAPHIC g712065g0225065525472.jpg GRAPHIC 1694
  Complete submission text file 0001193125-19-049058.txt   47149
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 19628121
SIC: 2836 Biological Products, (No Diagnostic Substances)